Viña Sean Matthew
Department of Sociology, The University of the Incarnate Word, 4301 Broadway, San Antonio, TX 78209, USA.
Healthcare (Basel). 2025 May 16;13(10):1158. doi: 10.3390/healthcare13101158.
: Structural inequalities in healthcare access may influence how individuals experience the psychological effects of psychedelic substances, potentially limiting positive outcomes among vulnerable populations. : This study uses data from the National Survey on Drug Use and Health (2008-2019; N = 484,732) to examine how public and private health insurance moderate the association between psychedelic use and psychological distress. Ordinary least squares (OLS) regression models indicate that private health insurance is associated with lower psychological distress, while public insurance is associated with higher distress. Psychedelic use moderates these associations, reinforcing the protective pattern linked to private insurance and intensifying distress among those with public coverage. These patterns vary by gender: among men, psychedelic use does not significantly alter the association between insurance type and distress; among women, however, psilocybin and lysergic acid diethylamide (LSD) use are associated with lower distress among those with private insurance, but with higher distress among those with public insurance. These findings indicate that while psychedelics may interact with existing healthcare conditions, they do not mitigate structural inequalities and may, in some cases, exacerbate them.
医疗保健可及性方面的结构性不平等可能会影响个体对致幻物质心理影响的体验，这有可能限制弱势群体获得积极结果。本研究使用来自全国药物使用和健康调查（2008 - 2019年；N = 484,732）的数据，来检验公共和私人医疗保险如何调节致幻剂使用与心理困扰之间的关联。普通最小二乘法（OLS）回归模型表明，私人医疗保险与较低的心理困扰相关，而公共保险则与较高的困扰相关。致幻剂的使用调节了这些关联，强化了与私人保险相关的保护模式，并加剧了有公共保险者的困扰。这些模式因性别而异：在男性中，致幻剂的使用并未显著改变保险类型与困扰之间的关联；然而在女性中，使用裸盖菇素和麦角酸二乙酰胺（LSD）与有私人保险者的较低困扰相关，但与有公共保险者的较高困扰相关。这些发现表明，虽然致幻剂可能会与现有的医疗状况相互作用，但它们并不能减轻结构性不平等，在某些情况下可能还会加剧这种不平等。
